Ixovex-1 clinical trials

Ixovex-1 Single Agent and Combination Therapy

This study is testing a new virus treatment, Ixovex-1, for advanced solid tumours and head and neck cancer. It aims to find a safe dose, alone and with Pembrolizumab, for patients who have limited other treatment options.